Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 81 entries
View as:

Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.

Phase: N/A Priority: Normal
NCT ID: NCT02718391 Org: User:
Start: 08/31/15 End: 11/30/19 Due: 11/30/20

Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation

Phase: N/A Priority: Normal
NCT ID: NCT05772390 Org: User:
Start: 03/31/23 End: 03/31/32 Due: 03/31/33

Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate in Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT04523688 Org: User:
Start: 03/25/21 End: 12/31/25 Due: 12/31/26

A Phase II Study on Adjuvant Vaccination with Dendritic Cells Loaded with Autologous Tumor Homogenate in Resected Stage IV Rare Cancers.

Phase: N/A Priority: Normal
NCT ID: NCT04166006 Org: User:
Start: 12/12/19 End: 12/31/31 Due: 12/31/32

Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04298892 Org: User:
Start: 01/07/20 End: 02/28/25 Due: 02/28/26

Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib

Phase: N/A Priority: Normal
NCT ID: NCT02786342 Org: User:
Start: 02/15/16 End: 06/30/21 Due: 06/30/22

Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT02488512 Org: User:
Start: 12/22/16 End: 02/23/18 Due: 02/23/19

Prospective Observational Study Comparing Calcium and Sodium Levofolinate in Combination With 5-Fluorouracil (5FU) /or in FOLFIRI Regimen

Phase: N/A Priority: Normal
NCT ID: NCT04680104 Org: User:
Start: 11/03/15 End: 08/06/19 Due: 08/06/20

Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT01848613 Org: User:
Start: 10/31/12 End: 05/31/18 Due: 05/31/19

Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy

Phase: N/A Priority: Normal
NCT ID: NCT03553212 Org: User:
Start: 10/30/18 End: 05/26/23 Due: 05/26/24

Key Performance Indicators for the Assessment of NSCLC Patients Pathway

Phase: N/A Priority: Normal
NCT ID: NCT04676321 Org: User:
Start: 10/01/20 End: 11/15/20 Due: 11/15/21

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06459024 Org: User:
Start: 06/28/24 End: 07/31/32 Due: 07/31/33

Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC

Phase: N/A Priority: Normal
NCT ID: NCT03226236 Org: User:
Start: 03/31/16 End: 03/31/19 Due: 03/31/20

Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03230734 Org: User:
Start: 09/01/17 End: 07/31/25 Due: 07/31/26

The Role of WB-MRI in the Evaluation of Prostate Cancer Patients Treated With Lutetium - Prostate Specific Membrane Antigen (Lu-PSMA)

Phase: N/A Priority: Normal
NCT ID: NCT05208229 Org: User:
Start: 02/01/21 End: 03/08/22 Due: 03/08/23

Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03454763 Org: User:
Start: 05/26/16 End: 01/31/25 Due: 01/31/26

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

Phase: N/A Priority: Normal
NCT ID: NCT06713837 Org: User:
Start: 02/27/25 End: 01/31/28 Due: 01/31/29

3 Tesla Magnetic Resonance Guided High Intensity Focused Ultrasound in the Treatment of Pain From Bone Metastases of Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02718404 Org: User:
Start: 09/14/15 End: 08/27/18 Due: 08/27/19

A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02131506 Org: User:
Start: 12/31/09 End: 01/31/16 Due: 01/31/17

Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor

Phase: N/A Priority: Normal
NCT ID: NCT02533765 Org: User:
Start: 09/11/15 End: 02/13/23 Due: 02/13/24

"Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL

Phase: N/A Priority: Normal
NCT ID: NCT06919393 Org: User:
Start: 10/23/19 End: 01/31/26 Due: 01/31/27

Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)

Phase: N/A Priority: Normal
NCT ID: NCT03454750 Org: User:
Start: 10/25/22 End: 05/22/24 Due: 05/22/25

Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04775290 Org: User:
Start: 08/02/19 End: 04/04/22 Due: 04/04/23

Italian Non-Interventional Study of FLT3 Mutated AML Patients

Phase: N/A Priority: Normal
NCT ID: NCT03547258 Org: User:
Start: 07/18/18 End: 05/31/21 Due: 05/31/22

177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02736448 Org: User:
Start: 05/31/16 End: 04/30/23 Due: 04/30/24